It highlights key developments in telomere biology, surfactant genes, and <i>MUC5B</i>, and discusses evidence-based strategies for screening and prevention, providing relevant insights for clinicians and researchers in ILD. This evidence concerns the gene MUC5B and interstitial lung disease.